MedPath

Fractional carbondioxide laser with and without platelet rich plasma therapy in treatment of acne scars

Completed
Conditions
Scar conditions and fibrosis of skin,
Registration Number
CTRI/2023/09/057562
Lead Sponsor
Dr Sanaga Mrudula
Brief Summary

This study is a randomized,double blind,parallel group,active control interventional study comparing the efficacy and safety profile of fractional co2 laser with and without platelet rich plasma therapy in the treatment of acne scars.This study will be conducted over a period of 1 year 3 months at a single centre in India. The primary outcome measures will be improvement in acne scars 1 month after each session.Secondary outcomes will be incidence of side effects which are assessed 1 week after each session.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
    1. Patients who are willing to take part in the research.
  • 2)Fitzpatrick’s skin type III-V patients aged 18-40 years with moderate to severe facial acne scars (i.e. Grade 3 and 4 according to Goodman and Baron qualitative grading of acne scars.
Exclusion Criteria
    1. Women who are pregnant or breastfeeding.
    1. Patients with local infection at the site of procedure (HSV, bacterial, etc,.) 3) Patients with a history of photosensitive disorders.
    1. Patients who have bleeding diathesis.
    1. Patients who are on anticoagulant therapy.
    1. Patients who are immunocompromised or taking any immunosuppressive drugs 7) Patients who are suffering from body dysmorphic syndrome or acne excoriee and those who have unrealistic expectations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in acne scar apperance1 month after each session
Secondary Outcome Measures
NameTimeMethod
incidence of Side effects1 week after each session

Trial Locations

Locations (1)

Katuri Medical College and Hospital

🇮🇳

Guntur, ANDHRA PRADESH, India

Katuri Medical College and Hospital
🇮🇳Guntur, ANDHRA PRADESH, India
Dr Sanaga Mrudula
Principal investigator
8125768669
mrudulasng1997@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.